Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Equillium, Inc. (EQ)

Equillium Q2 2026 net loss narrows to $4.7 million from $5.7 million a year earlier

Positive Impact 3 of 5 earnings Written later

Equillium reported a second-quarter 2026 net loss of $4.7 million, or $(0.04) per share, compared with $5.7 million, or $(0.16) per share, a year earlier. The company said its $57.2 million in cash is expected to fund planned operations into 2029, and it reiterated that a Phase 1 study of EQ504 is expected to begin in the fourth quarter of 2026.

Key points

  • Net loss for Q2 2026 was $4.7 million, or $(0.04) per basic and diluted share, versus $5.7 million, or $(0.16) per share, in Q2 2025.
  • R&D expenses were $2.8 million, down from $4.1 million a year earlier; G&A expenses were $2.4 million, up from $2.1 million.
  • Cash and cash equivalents were $57.2 million as of June 30, 2026, down from $61.3 million as of March 31, 2026.
  • Weighted-average shares outstanding were 111,805,635 in Q2 2026, compared with 35,719,317 in Q2 2025.

The filing

CompanyEquillium, Inc. (EQ)
Form8-K, current report
Filed with the SECAug 13, 2026, 4:10 PM ET
Accession number0001193125-26-349182

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:43 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 13, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.